Luminary Therapeutics
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma (NCT07771361) | Luminary Therapeutics | 2026-12-01 |
| BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease (NCT07729995) | Luminary Therapeutics | 2026-10-01 |
| BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies (NCT07679919) | Luminary Therapeutics | 2026-09-01 |
| BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus (NCT06340750) | Luminary Therapeutics | 2025-04-01 |
| LMY-920 for Treatment of Relapsed or Refractory Myeloma (NCT05546723) | Luminary Therapeutics | 2024-03-13 |
| Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma (NCT05312801) | Luminary Therapeutics | 2023-11-21 |
Track Luminary Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.